Wells Fargo & Company MN Buys 59,003 Shares of Chemours Company (The) (CC)

Wells Fargo & Company MN raised its position in Chemours Company (The) (NYSE:CC) by 21.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 331,492 shares of the specialty chemicals company’s stock after buying an additional 59,003 shares during the period. Wells Fargo & Company MN owned 0.18% of Chemours Company (The) worth $12,762,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Keybank National Association OH bought a new stake in shares of Chemours Company (The) during the fourth quarter worth $212,000. FMR LLC increased its stake in shares of Chemours Company (The) by 481.3% in the fourth quarter. FMR LLC now owns 10,926,459 shares of the specialty chemicals company’s stock worth $241,366,000 after buying an additional 9,046,728 shares in the last quarter. Federated Investors Inc. PA increased its stake in shares of Chemours Company (The) by 134,344.4% in the fourth quarter. Federated Investors Inc. PA now owns 72,600 shares of the specialty chemicals company’s stock worth $1,603,000 after buying an additional 72,546 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Chemours Company (The) by 51.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 491,439 shares of the specialty chemicals company’s stock worth $10,856,000 after buying an additional 167,183 shares in the last quarter. Finally, State Street Corp increased its stake in shares of Chemours Company (The) by 8.1% in the fourth quarter. State Street Corp now owns 4,287,135 shares of the specialty chemicals company’s stock worth $94,703,000 after buying an additional 321,567 shares in the last quarter. Institutional investors own 75.01% of the company’s stock.

Institutional Ownership by Quarter for Chemours Company (The) (NYSE:CC)

Chemours Company (NYSE:CC) traded up 3.54% during mid-day trading on Monday, reaching $38.00. 3,580,495 shares of the company traded hands. The firm has a market capitalization of $7.01 billion, a P/E ratio of 66.43 and a beta of 3.55. Chemours Company has a 12-month low of $5.82 and a 12-month high of $46.02. The company’s 50 day moving average price is $41.19 and its 200 day moving average price is $32.93.

Chemours Company (The) (NYSE:CC) last released its quarterly earnings data on Monday, May 1st. The specialty chemicals company reported $0.75 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.50 by $0.25. The company had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.32 billion. Chemours Company (The) had a return on equity of 125.69% and a net margin of 1.91%. The firm’s revenue for the quarter was up 10.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.06 earnings per share. Equities research analysts predict that Chemours Company will post $3.27 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 15th. Shareholders of record on Wednesday, May 17th were given a $0.03 dividend. The ex-dividend date of this dividend was Monday, May 15th. This represents a $0.12 dividend on an annualized basis and a yield of 0.32%. Chemours Company (The)’s dividend payout ratio is currently 22.22%.

COPYRIGHT VIOLATION WARNING: “Wells Fargo & Company MN Buys 59,003 Shares of Chemours Company (The) (CC)” was first posted by BBNS and is the property of of BBNS. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright & trademark law. The original version of this story can be accessed at https://baseballnewssource.com/markets/wells-fargo-company-mn-has-12-762-million-stake-in-chemours-co-cc-updated-updated/862751.html.

CC has been the topic of several research reports. Jefferies Group LLC raised shares of Chemours Company (The) from a “hold” rating to a “buy” rating and lifted their price target for the stock from $35.00 to $48.00 in a research note on Wednesday, March 29th. Citigroup Inc. lifted their price target on shares of Chemours Company (The) from $62.00 to $63.00 and gave the stock a “buy” rating in a research note on Monday, April 17th. ValuEngine raised shares of Chemours Company (The) from a “hold” rating to a “buy” rating in a research note on Friday, June 2nd. BidaskClub downgraded shares of Chemours Company (The) from a “buy” rating to a “hold” rating in a research note on Saturday. Finally, J P Morgan Chase & Co raised shares of Chemours Company (The) from a “neutral” rating to an “overweight” rating and lifted their target price for the stock from $39.00 to $50.00 in a research note on Friday, May 12th. Two equities research analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $42.00.

In other Chemours Company (The) news, insider Paul Kirsch sold 19,036 shares of Chemours Company (The) stock in a transaction on Monday, June 5th. The stock was sold at an average price of $41.42, for a total value of $788,471.12. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, VP Erich Parker sold 4,908 shares of Chemours Company (The) stock in a transaction on Tuesday, May 16th. The shares were sold at an average price of $45.53, for a total value of $223,461.24. The disclosure for this sale can be found here. Insiders sold 46,725 shares of company stock worth $1,919,300 in the last 90 days. Company insiders own 1.14% of the company’s stock.

About Chemours Company (The)

The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins.

Receive News & Ratings for Chemours Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours Company (The) and related companies with our FREE daily email newsletter.

 


Latest News

Hitters in Major League Baseball on Record Home Run Pace
Hitters in Major League Baseball on Record Home Run Pace
Atlanta Considering Playing Freddie Freeman at Third
Atlanta Considering Playing Freddie Freeman at Third
Injury to Gleyber Torres Adds to Questions About Yankees
Injury to Gleyber Torres Adds to Questions About Yankees
Game Winning Home Run Completes Nolan Arenado Cycle
Game Winning Home Run Completes Nolan Arenado Cycle
New York Yankees and Masahiro Tanaka Hit Hard Again
New York Yankees and Masahiro Tanaka Hit Hard Again
Victor Martinez Diagnosed with Irregular Heartbeat
Victor Martinez Diagnosed with Irregular Heartbeat


Leave a Reply

 
© 2006-2017 BBNS.